; (B) by striking Free and inserting 4.4% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (33) Metconazole Heading 9902.06.80 is amended— (A) by amending the article description to read as follows: 5-[(4-Chlorophenyl)methyl]-2,2-dimethyl-1-(1,2,4-triazol- 1-ylmethyl)cyclopentan-1-ol (Metconazole) (CAS No. 125116–23–6) (provided for in subheading 2933.99.22) ; (B) by striking 1.6% and inserting Free ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (34) Prothioconazole Heading 9902.06.81 is amended— (A) by amending the article description to read as follows: 2-[(2RS)-2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2H-1,2,4-triazole-3(4H)-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 2933.99.22) ; (B) by striking 5.3% and inserting 5.7% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (35) Flutriafol Heading 9902.06.84 is amended— (A) by amending the article description to read as follows: 1-(2-Fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4- triazol-1-yl)ethanol (Flutriafol) (CAS No. 76674–21–0) (provided for in subheading 2933.99.22) ; (B) by striking 0.2% and inserting 3% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (36) Ipconazole Heading 9902.06.85 is amended— (A) by amending the article description to read as follows: (1R,2S,5R)-2-(4-Chlorobenzyl)-5-isopropyl-1-(1H-1,2,4- triazol-1-ylmethyl)cyclopentanol (Ipconazole) (CAS No. 125225–28–7) (provided for in subheading 2933.99.22) ; (B) by striking Free and inserting 1.3% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (37) Hexythiazox Heading 9902.06.99 is amended— (A) by amending the article description to read as follows: (4RS,5RS)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2- oxo-1,3-thiazolidine-3-carboxamide (Hexythiazox) (CAS No. 78587–05–0) (provided for in subheading 2934.10.10) ; (B) by striking 1.8% and inserting 2.4%